FIELD: medicine; pharmaceutics.
SUBSTANCE: present invention relates to a pharmaceutical composition for local application containing 5% by weight of luliconazole or its pharmaceutically acceptable salt, and from 16% to 60% by weight of dimethyl sulphoxide, from 40% to 75% by weight of ethanol, from 1% to 5% by weight of lactic acid, from 1% to 30% by weight of monoethyl ether of diethylene glycol and from 0.5% to 1% by weight of methylvinyl ether-maleic anhydride of the total weight of the composition, and wherein said composition has pH of 2 to 8.
EFFECT: present invention provides a pharmaceutical composition of luliconazole for local application, having high chemical stability during storage and good penetrating power of luliconazole.
7 cl, 4 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
GEL COMPOSITION FOR TREATMENT OF STOMATOLOGICAL DISEASE AND METHOD FOR ITS PREPARING | 2004 |
|
RU2288699C2 |
PHARMACEUTICAL COMPOSITION COMPRISING LULICONAZOLE | 2013 |
|
RU2621615C2 |
PHARMACEUTICAL COMPOSITION SHOWING ANTIFUNGAL EFFECT | 1992 |
|
RU2110257C1 |
GALENIC COMPOSITION CONTAINING A DRUG FOR TOPICAL APPLICATION | 2016 |
|
RU2699022C1 |
HIGHLY CONCENTRATED COMPOSITION | 2016 |
|
RU2731564C2 |
COMPOSITIONS FOR LOCAL APPLICATION CONTAINING BIMATOPROST, AND METHODS FOR HAIR GROWTH STIMULATION WITH HELP THEREOF | 2014 |
|
RU2703713C2 |
PHARMACEUTICAL COMPOSITION CONTAINING ANTIFUNGAL AGENT AS AN ACTIVE INGREDIENT | 2020 |
|
RU2799329C1 |
ISOXAZOLINE COMPOSITIONS | 2014 |
|
RU2688919C1 |
PHARMACEUTICAL COMPOSITION OF TAXOIDS | 2011 |
|
RU2603833C2 |
ISOXAZOLINE COMPOSITIONS AND THEIR USE IN THE PREVENTION OR TREATMENT OF PARASITIC INFESTATIONS OF ANIMALS | 2014 |
|
RU2791637C2 |
Authors
Dates
2024-07-29—Published
2022-01-26—Filed